摘要
海马和杏仁核是阿尔茨海默病 (AD)发病早期易受攻击的大脑区域。然而,以往的研究主要集中于在AD病理中表征海马,而很少研究杏仁核。在这里,我们研究 了广泛应用于AD造模的年轻(2、3和4个月大)双转基因(Tg)APP/PS1小鼠海马和杏仁核中神经元的结构和功能。与野生型同窝小鼠相比,这三个年龄阶段的Tg 小鼠杏仁核占主导地位的记忆变差。而一直到4个月大,海马占主导地位的记忆保持完整。同样,2月龄Tg小鼠基底外侧杏仁核神经元的树突减少,而在海马CA1区和CA3区的神经元树突保持相对完整。年轻Tg小鼠杏仁核中脑源性神经营养因子信号转导通路(如AKT和PKC))减弱,而在在海马中不变。此外 5-HT 的降低和 Aβ水平的升高也较早出现在杏仁核内,并且比海马更为明显。5-HT和Aβ 之间的负相关在杏仁核是显而易见的,而在海马中并不存在这种对应关系。总之,这些结果表明,神经退行性疾病的早于海马发生在杏仁核中。我们认为,杏仁核的功能应该被应用作为诊断因AD引起的轻度认知功能障碍的认知筛查工具。
关键词: 阿尔茨海默病、杏仁核、树突、海马、学习记忆、可塑性。
Current Alzheimer Research
Title:Neurodegeneration in Amygdala Precedes Hippocampus in the APPswe/ PS1dE9 Mouse Model of Alzheimer’s Disease
Volume: 12 Issue: 10
Author(s): Tzu-Wei Lin, Yu-Fan Liu, Yao-Hsiang Shih, Shean-Jen Chen, Tung-Yi Huang, Chia-Yuan Chang, Chi-Hsiang Lien, Lung Yu and Shun-Hua Chen and Yu-Min Kuo
Affiliation:
关键词: 阿尔茨海默病、杏仁核、树突、海马、学习记忆、可塑性。
摘要: Both the hippocampus and amygdala are early vulnerable brain regions in the development of Alzheimer’s disease (AD). However, previous studies mainly focused on characterizing the hippocampus in the pathophysiology of AD, leaving the amygdala less explored. Here, we characterized the structures and functions of neurons in the hippocampus and amygdala of young (2, 3 and 4 months of age) APP/PS1 double transgenic (Tg) mice, a widely used AD mouse model. Compared to wild-type littermates (Wt ), Tg mice performed worse in amygdala-dominant memory at all three ages, while hippocampus-dominant memory remained intact until 4-month-old. Likewise, the dendritic arbors of neurons in the basolateral amygdala were reduced in Tg mice as early as 2-months-old, while the dendritic arbors of neurons in the hippocampal CA1 and CA3 regions were relatively intact. BDNF signaling pathways (e.g. AKT and PKC) were reduced in the amygdala, but not in the hippocampus, of young Tg mice. Furthermore, reduction of 5-HT and elevation of Aβ levels also occurred earlier in the amygdala and were more pronounced than those in the hippocampus. Negative correlations between the levels of 5-HT and Aβ were evident in the amygdala, but not in the hippocampus. Taken together, these results suggest that neurodegeneration occurs earlier in the amygdala than in the hippocampus. We suggest that amygdala function should be incorporated into the cognitive screening tool for the diagnosis of mild cognitive impairment due to AD.
Export Options
About this article
Cite this article as:
Tzu-Wei Lin, Yu-Fan Liu, Yao-Hsiang Shih, Shean-Jen Chen, Tung-Yi Huang, Chia-Yuan Chang, Chi-Hsiang Lien, Lung Yu and Shun-Hua Chen and Yu-Min Kuo , Neurodegeneration in Amygdala Precedes Hippocampus in the APPswe/ PS1dE9 Mouse Model of Alzheimer’s Disease, Current Alzheimer Research 2015; 12 (10) . https://dx.doi.org/10.2174/1567205012666151027124938
DOI https://dx.doi.org/10.2174/1567205012666151027124938 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroprotective Appraisal of Methanolic Extract of Flowers of Nerium oleander in a Non Classical Rat Model of Alzheimer Disease
The Natural Products Journal Cholinergic Treatment of Traumatic Brain Injury
Current Drug Therapy β-Synuclein Assembly as a Therapeutic Target of Parkinsons Disease and Related Disorders
Current Pharmaceutical Design Pharmacological Management of Huntingtons Disease: An Evidence- Based Review
Current Pharmaceutical Design Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease
Current Neuropharmacology Advancements in Treatment Options of Women Infertility
Current Women`s Health Reviews Effect of Lithium on Neurocognitive Functioning
Current Alzheimer Research Coronary Artery Bypass Graft in HIV-Infected Patients: A Multicenter Case Control Study
Current HIV Research Daidzein and its Effects on Brain
Current Medicinal Chemistry Genotoxicity in Alzheimers Disease: Role of Amyloid
Current Alzheimer Research Experience and Perspectives of Caregivers of Spouse with Mild Cognitive Impairment
Current Alzheimer Research Metal and Inflammatory Targets for Alzheimers Disease
Current Drug Targets Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era
Current Cancer Drug Targets AβPP-induced UPR Transcriptomic Signature of Glial Cells to Oxidative Stress as an Adaptive Mechanism to Preserve Cell Function and Survival
Current Alzheimer Research Retinoic Acid and the Gut Microbiota in Alzheimer’s Disease: Fighting Back-to-Back?
Current Alzheimer Research New Perspectives of Alzheimer Disease Diagnosis – the Most Popular and Future Methods
Medicinal Chemistry Protective Effects of Polydatin Against Dementia-Related Disorders
Current Neuropharmacology Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Novel Kynurenic Acid Analogues in the Treatment of Migraine and Neurodegenerative Disorders: Preclinical Studies and Pharmaceutical Design
Current Pharmaceutical Design Applications of Artificial Neural Networks in Medical Science
Current Clinical Pharmacology